U.S. Markets closed

MEI Pharma Inc (MEIP) Receives $7.00 Consensus Price Target from Analysts

The Cerbat Gem

MEI Pharma Inc (NASDAQ:MEIP) has earned a consensus recommendation of “Buy” from the six research firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average